-transparent.png){kind=logo}
A murine mAb BAT123 (Ab1) directing to the principal neutralization site of human T cell leukemia virus (HTLV)-IIIB gp120 (amino acid residue 308-322) was used to generate syngeneic anti-Id mAb (Ab2). Among the Ab2, a mAb AB19-4 was characterized by both serologic and biologic methods to be paratope-specific (Ab2 beta), bearing the internal image of the neutralization site. AB19-4 was found to bind specifically to BAT123 and also to its mouse-human chimeric form in ELISA. The binding of AB19-4 to BAT123 was specifically inhibited by HTLV-IIIB gp120 and the synthetic epitope peptides of HTLV-IIIB and HTLV-IIIMN defined by BAT123. AB19-4 also inhibited the binding of BAT123 to HTLV-IIIB-infected H9 cells in flow cytometric studies. Polyclonal goat and sheep antisera against HTLV-IIIB gp120 reacted specifically with AB19-4, suggesting that AB19-4 may recognize cross-species idiotopes. Rabbits immunized with purified AB19-4 generated anti-anti-Id antibodies (Ab3) that reacted specifically with HTLV-IIIB gp120 and the BAT123-binding epitope peptides of HTLV-IIIB and HTLV-IIIMN. The Ab3 bound to H9 cells infected by HTLV-IIIB or HTLV-IIIMN and inhibited the infection of CEM cells by HTLV-IIIB or HTLV-IIIMN, whereas BAT123 also bound H9 cells infected by HTLV-IIIB or HTLV-IIIMN but neutralized only HTLV-IIIB. Our data suggest that AB19-4 mimics the neutralization site on HIV-1 gp120 defined by BAT123. The induction of immunity to HIV using internal-image Ab2 to HIV-neutralizing antibodies may provide a viable approach for developing effective vaccines for AIDS.
M S Fung, and
C R Sun, and
R S Liou, and
W Gordon, and
N T Chang, and
T W Chang, and
N C Sun
December 1993,
AIDS (London, England),
M S Fung, and
C R Sun, and
R S Liou, and
W Gordon, and
N T Chang, and
T W Chang, and
N C Sun
March 2002,
AIDS (London, England),
M S Fung, and
C R Sun, and
R S Liou, and
W Gordon, and
N T Chang, and
T W Chang, and
N C Sun
April 1992,
Proceedings of the National Academy of Sciences of the United States of America,
M S Fung, and
C R Sun, and
R S Liou, and
W Gordon, and
N T Chang, and
T W Chang, and
N C Sun
January 2008,
PloS one,
M S Fung, and
C R Sun, and
R S Liou, and
W Gordon, and
N T Chang, and
T W Chang, and
N C Sun
October 1990,
AIDS (London, England),
M S Fung, and
C R Sun, and
R S Liou, and
W Gordon, and
N T Chang, and
T W Chang, and
N C Sun
February 2019,
Journal of immunology (Baltimore, Md. : 1950),
M S Fung, and
C R Sun, and
R S Liou, and
W Gordon, and
N T Chang, and
T W Chang, and
N C Sun
April 1994,
Virology,
M S Fung, and
C R Sun, and
R S Liou, and
W Gordon, and
N T Chang, and
T W Chang, and
N C Sun
January 1993,
Journal of acquired immune deficiency syndromes,
M S Fung, and
C R Sun, and
R S Liou, and
W Gordon, and
N T Chang, and
T W Chang, and
N C Sun
December 1988,
Journal of immunological methods,
M S Fung, and
C R Sun, and
R S Liou, and
W Gordon, and
N T Chang, and
T W Chang, and
N C Sun
October 1994,
Molecular immunology,
